Top Suppliers:I want be here

14149-31-6

14149-31-6 structure
14149-31-6 structure
  • Name: 2,6-Piperidinedione,4-phenyl-
  • Chemical Name: 4-phenylpiperidine-2,6-dione
  • CAS Number: 14149-31-6
  • Molecular Formula: C11H11NO2
  • Molecular Weight: 189.21100
  • Create Date: 2016-06-23 17:01:25
  • Modify Date: 2024-01-03 18:28:40

Name 4-phenylpiperidine-2,6-dione
Synonyms 3-Phenylglutarimide
Glutarimide,3-phenyl
4-Phenyl-2,6-piperidinedione
4-phenyl-piperidine-2,6-dione
4-phenylglutarimide
4-Phenyl-piperidin-2,6-dion
4-phenyl-piperidin-2,6-dione
Density 1.185g/cm3
Boiling Point 392.3ºC at 760mmHg
Melting Point 173-174℃
Molecular Formula C11H11NO2
Molecular Weight 189.21100
Flash Point 176.6ºC
Exact Mass 189.07900
PSA 46.17000
LogP 1.53560
Vapour Pressure 2.31E-06mmHg at 25°C
Index of Refraction 1.553
Storage condition 2-8℃

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MA5350000
CHEMICAL NAME :
Glutarimide, 3-phenyl-
CAS REGISTRY NUMBER :
14149-31-6
BEILSTEIN REFERENCE NO. :
0146423
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C11-H11-N-O2
MOLECULAR WEIGHT :
189.23
WISWESSER LINE NOTATION :
T6VMVTJ ER

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
80 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 10,243,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 173,115,1968
HS Code 2925190090

~79%

14149-31-6 structure

14149-31-6

Literature: Klinge Pharma GmbH Patent: EP1042315 B1, 2004 ; Location in patent: Page 59 ;

~72%

14149-31-6 structure

14149-31-6

Literature: Romeo, Giuseppe; Materia, Luisa; Modica, Maria N.; Pittal, Valeria; Salerno, Loredana; Siracusa, Maria A.; Manetti, Fabrizio; Botta, Maurizio; Minneman, Kenneth P. European Journal of Medicinal Chemistry, 2011 , vol. 46, # 7 p. 2676 - 2690

~98%

14149-31-6 structure

14149-31-6

Literature: Rani; Cui; Ubukata; Osada Journal of Antibiotics, 1995 , vol. 48, # 10 p. 1179 - 1181

~61%

14149-31-6 structure

14149-31-6

Literature: Kinoshita, Takamasa; Okamoto, Kazuko; Clardy, Jon Synthesis, 1985 , # 4 p. 402 - 403

~%

14149-31-6 structure

14149-31-6

Literature: Burger; Hofstetter Journal of Organic Chemistry, 1959 , vol. 24, p. 1290,1292

~%

14149-31-6 structure

14149-31-6

Literature: Mallard; Wilson Journal of the American Pharmaceutical Association (1912-1977), 1957 , vol. 46, p. 176
HS Code 2925190090
Summary 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%